Codexis, Inc. CDXS 深 沪
等待开盘 03-26 09:30:00 美东时间
1.755
+0.085
+5.09%
华盛通- 最 高1.7893
- 今 开1.69
- 成交量 79.80万股
- 最 低 1.69
- 昨 收 1.67
- 总市值 1.59亿
- 52周最高 3.87
- 市盈率 静 --
- 换手率 0.88%
- 52周最低 0.9583
- 委 比 27.46%
- 总股本 9032.44万
- 历史最高 42.01
- 量 比 0.55
- 振 幅 5.95%
- 历史最低 0.9583
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | Lightwave飙升41%，与Tower半导体合作，推进电光聚合器技术商业化；塞拉尼斯大涨14%
Lightwave飙升41%，与Tower半导体合作，推进电光聚合器技术商业化；WOOF大涨34%，财报超预期获机构上调评级；塞拉尼斯大涨14%，霍尔木兹海峡持续封锁催高公司产品价格>>
03-13 15:45
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours?
Codexis shares jumped 37.8% in after-hours trading after the company reported a profitable fourth quarter and full-year 2025 revenue growth.
03-12 13:25
Codexis shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance above estimates.
Codexis shares are trading higher after the company reported better-than-expect...
03-12 04:17
Earnings Scheduled For March 11, 2026
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Preview: Codexis's Earnings
Codexis (NASDAQ:CDXS) is preparing to release its quarterly earnings on Wednesd...
03-11 01:01
Codexis Inks Deal With Pharmaceutical Firm To Manufacture siRNA Material
Codexis, Inc. (NASDAQ:CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced it has entered into an agreement with an innovator pharmaceutical company to
03-04 23:08
Codexis Achieves ISO 9001:2015 Certification
Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned its ISO 9001:2015 certification. The official certification
02-10 22:11
Codexis Announces Signing of Lease for GMP Manufacturing Facility
Codexis leased a 34,000 sq. ft GMP facility in Hayward, California, expanding its manufacturing capabilities for drug substances using the ECO Synthesis platform. Starting early 2026, the facility will produce oligonucleotides and support early-clinical trials through enhanced quality and service flexibility.
2025-11-10 14:00
Codexis shares are trading lower after the company reported worse-than-expected Q3 financial results.
Codexis shares are trading lower after the company reported worse-than-expected...
2025-11-07 06:05
In October, Codexis Announces Signing Of $37.8M Supply Assurance Agreement with Merck, Reduced Around 24% Of Its Workforce
As of September 30, 2025, the Company had $58.7 million in cash, cash equivalents and short-term investments.In November 2025, Codexis eliminated 46 positions, or approximately 24% of its workforce. The company expects
2025-11-07 05:50
